Comparative Effectiveness: A Real-World Users Guide
|Event Date/Time: Mar 14, 2012||End Date/Time: Mar 15, 2012|
levels of evidence of comparative eff ectiveness applied within health technology assessments (HTAs). The goal of the meeting is to focus
less on defi nitions and theoretic concepts, and more on the application of comparative
effectiveness research (CER) and HTA within drug
development and research planning.
While the discussion of CER has been ongoing for years, the recent creation of the Patient-Centered Outcomes Research Institute (PCORI)
within health care reform, as well as new standards for evidence evaluation
development by leading payers, have made understanding not just the theories, but rather their applications, of vital importance. This
meeting will push beyond the basic questions to evaluate the importance of CER and provide participants with actionable understandings
of how CER evidence can be better managed and developed within their own organizations.
Unlike previous eff orts in this area, this meeting will provide participants with a â€œwhat does it mean for meâ€ perspective on CER and HTA,
providing take-aways to apply within day-to-day drug development and marketing positions.